Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients
NCT ID: NCT00357955
Last Updated: 2024-11-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
118 participants
INTERVENTIONAL
2004-08-31
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic
NCT00358033
Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program
NCT00013052
Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes
NCT00409240
Pharmacist-led Group Medical Visits to Help With Diabetes Management
NCT00554671
Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes
NCT00964587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MEDIC
Multidisciplinary education and diabetes intervention for cardiac risk reduction
Behavioral counseling and peer support
Multidisciplinary education and diabetes intervention for cardiac risk reduction - pharmacist led group intervention
Interactive Education
interactive lectures with hands-on learning
Role modeling
learning from peers with similar disease and problems
Pharmacologic case management
provided by clinical pharmacists following pre-established algorithms
usual care
usual care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral counseling and peer support
Multidisciplinary education and diabetes intervention for cardiac risk reduction - pharmacist led group intervention
Interactive Education
interactive lectures with hands-on learning
Role modeling
learning from peers with similar disease and problems
Pharmacologic case management
provided by clinical pharmacists following pre-established algorithms
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rhode Island Foundation
OTHER
Providence VA Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wen-Chih Wu
Staff Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wen-Chih Wu, MD
Role: PRINCIPAL_INVESTIGATOR
Providence VAMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Providence VAMC
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SA, Pirraglia PA, Wu WC. Pharmacist-led group medical appointment model in type 2 diabetes. Diabetes Educ. 2010 Jan-Feb;36(1):109-17. doi: 10.1177/0145721709352383. Epub 2009 Dec 4.
Khatana SA, Taveira TH, Choudhary G, Eaton CB, Wu WC. Change in hemoglobin A(1c) and C-reactive protein levels in patients with diabetes mellitus. J Cardiometab Syndr. 2009 Spring;4(2):76-80. doi: 10.1111/j.1559-4572.2008.00042.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12733
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.